Cullinan Therapeutics, Inc.
CGEM • NASDAQ
Cullinan Therapeutics, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Nadim Ahmed, with a market cap of $777.8M.
CEONadim Ahmed
Next Earnings
Upcoming earnings announcement for Cullinan Therapeutics, Inc.
Date
Thursday, May 7, 2026 (in a month)
Timing
Before Market Open (7:00 AM New York)
Fiscal Period
Q1 2026
EPS Estimate
-$0.83
Revenue Estimate
$6.9M
Earnings History
Past 12 earnings reports for Cullinan Therapeutics, Inc.
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Mar 10, 2026 | Q4 2025 | -$0.77Est: -$0.82 | +6.1% | -Est: $9.9M | -100.0% |  10-K |
| Nov 6, 2025 | Q3 2025 | -$0.77Est: -$0.92 | +16.3% | - | — | 10-Q |
| Aug 7, 2025 | Q2 2025 | -$1.07Est: -$0.85 | -25.9% | - | — | 10-Q |
| May 8, 2025 | Q1 2025 | -$0.74Est: -$0.83 | +10.8% | - | — | 10-Q |
| Feb 27, 2025 | Q4 2024 | -$0.73Est: -$0.80 | +8.8% | - | — | 10-K |
| Nov 7, 2024 | Q3 2024 | -$0.69Est: -$0.81 | +14.8% | - | — | 10-Q |
| Aug 8, 2024 | Q2 2024 | -$0.75Est: -$0.73 | -2.7% | - | — | 10-Q |
| May 15, 2024 | Q1 2024 | -$0.86Est: -$0.95 | +9.5% | - | — | 10-Q |
| Mar 14, 2024 | Q4 2023 | -$0.54Est: -$0.96 | +43.7% | - | — | 10-K |
| Nov 8, 2023 | Q3 2023 | -$0.91Est: -$0.92 | +1.1% | - | — | — |
| Aug 10, 2023 | Q2 2023 | -$0.82Est: -$0.97 | +15.5% | - | — | 10-Q |
| May 11, 2023 | Q1 2023 | -$1.42Est: -$0.98 | -44.9% | - | — | — |